2 / 68
Dyna Gliclazide SR 30 mg
. Each modified release tablet contains 30 mg gliclazide. Reg. No.: RSA S3 42/21.2/0249 NAM NS2 12/21.2/0110. For full prescribing information, refer to the package insert approved by the Medicines Control Council,
10 December 2011.
1)
Crepaldi G and Fioretto P.Gliclazide modified release: Its place in the therapeutic armamentarium.Metabolism 2000;49(10)supplement 2:21-25.
2)
McGavin JK,
et al
.Gliclazide modified release.Drugs 2002;62(9):1357-1364.
3)
The 2012 SEMDSA guideline for the management of type 2 diabetes - Glucose control: Non-insulin therapies. JEMDSA 2012;17(2):S23-S31.
4)
Department of health website
http://www.doh.gov.za– Accessed 26 March 2015. * Sulphonylureas
DGLD199/06/2015
.
for
SUSTAINED
CONTROL
R46,94
SEP excl. VAT
Once daily formulation
Improved compliance
1
Sustained 24 hour glycaemic control
2
SUs* are the preferred add-on therapy to metformin
3
60
’
s
Packed in
23
%
less
vs.
market
leader
4
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Tel
021 707 7000
Fax
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.za